ABOUT

---

In-depth profiles of leading-edge companies and technologies, including the most important new trends in the biopharma, medtech and diagnostics industries.

---

Staff | Free Trial | Subscribe/Renew | Advertise

START-UP is the premier source for business intelligence on the newest companies and emerging technologies. START-UP is dedicated to helping you find and accurately evaluate real business development, licensing, and investment opportunities more efficiently than you ever imagined possible. In every issue, you get intel on new and emerging technologies; business models; financing strategies; VC and other early stage funding sources; deal profiles; and even tech transfers.

Who Reads START-UP?

Top-level pharmaceutical and biotechnology business development executives use START-UP to evaluate future markets, identify and profit from venture opportunities, identify competitive threats and more. START-UP delivers profiles of leading-edge companies and technology, including the most important new trends, licensing deals, investment opportunities, business models, financing strategies, and abundant deals data. Use START-UP to evaluate opportunities and threats that will guide your business development strategy.